Trifluoromethanesulfonic Acid Efficiently Catalyzed the Intramolecular Glycosidation of 1-C-Alkyl-d-hexopyranoses to Form the Anhydroketopyranoses Having 6,8-Dioxabicyclo[3.2.1]octane Structures

Abstract

The intramolecular glycosidation of the 1-C-alkyl-d-hexopyranose derivatives to form the anhydroketopyranoses having 6,8-dioxabicyclo[3.2.1]octane structures was investigated. We synthesized several 1-C-alkyl-2,3,4-tri-O-benzyl-d-hexopyranoses and found that only 5 mol% trifluoromethanesulfonic acid efficiently promoted the intramolecular glycosidation to afford the desired anhydroketopyranoses in good yields.

anhydro form - anhydroketopyranose - 1-C-alkyl-hexo­pyranose - intramolecular glycosidation - trifluoromethanesulfonic acid

References

For example, see:

1a Procopiou PA. Bailey EJ. Chan C. Inglis GGA. Lester MG. Srikantha ARP. Sidebottom PJ. Watson NS. J. Chem. Soc., Perkin Trans. 1  1995,  1341 

1b Hatano T. Yoshihara R. Hattori S. Yoshizaki M. Shingu T. Okuda T. Chem. Pharm. Bull.  1992,  40:  1703 

1c Richtmyer NK. Methods Carbohydr. Chem.  1962,  49:  167 

1d Takenaka M. Ono H. Tetrahedron Lett.  2003,  44:  999 

For example, see:

2a Hanessian S. Total Synthesis of Natural Products: The ‘Chiron’ Approach   Pergamon Press; Oxford: 1983. 

2b Bols M. Carbohydrate Building Blocks   John Wiley; New York: 1996.  p.43-48  

3a Haricoviniova-Bilikova Z. Petrus L. Carbohydr. Res.  1999,  320:  31 

3b Haricoviniova-Bilikova Z. Synthesis  2001,  751 

4 Francisco CG. Herrera AJ. Suarez E. J. Org. Chem.  2002,  67:  7439 

5a Kraus GA. Molina MT. J. Org. Chem.  1988,  53:  752 

5b Czernecki S. Ville G. J. Org. Chem.  1989,  54:  610 

6a Schlesselmann P. Fritz H. Lehmann J. Uchiyama T. Brewer CF. Hehre EJ. Biochemistry  1982,  21:  6606 

6b Brockhaus M. Lehmann J. Carbohydr. Res.  1977,  53:  21 

6c Li X. Ohtake H. Takahashi H. Ikegami S. Synlett  2001,  1885 

6d Penner M. Taylor D. Desautels D. Marat K. Schweizer F. Synlett  2005,  212 

7a Li X. Ohtake H. Takahashi H. Ikegami S. Tetrahedron  2001,  57:  4297 

7b As the analogues of the 1-C-alkyl-hexopyranose derivatives, the glycosidation using the 1-C-alkoxyalkyl-hexopyranose derivatives was reported. See: Heskamp BM. Veeneman GH. van der Marel GA. van Boeckel CAA. van Boom JH. Tetrahedron  1995,  51:  5657 

7c As the 1-C-alkyl-hexofuranose derivative, the glycosidation using 2,3:5,6-di-O-isopropyl-idene-1-C-methyl-d-mannofuranosyl acetate was reported. See: Dondoni A. Marra A. Rojo I. Scherrmann M.-C. Tetrahedron  1996,  52:  3057 

8 Yamanoi T. Oda Y. Yamazaki I. Shinbara M. Morimoto K. Matsuda S. Lett. Org. Chem.  2005,  2:  242 

Compounds 1a-e and 6a were synthesized as follows (Scheme 3). The reaction of 6-O-acetyl-2,3,4-tri-O-benzyl-d-glucopyranose (9) using DMSO-Ac₂O gave the corresponding 6-O-acetyl-2,3,4-tri-O-benzyl-d-glucono-1,5-lactone (10) in the good yield of 92%. The alkyl groups were then introduced into C-1 of 10 by the reaction of the carbonyl group at C-1 with organometallic reagents such as RMgX or RLi. The reaction of 10 with MeLi (2.4 equiv) in dry THF at -78 °C gave 6-O-acetyl-2,3,4-tri-O-benzyl-1-C-methyl-α-d-glucopyranose (11a) and 2,3,4-tri-O-benzyl-1-C-methyl-α-d-glucopyranose (1a) in 14% and 64% yields, respectively. The treatment of 11a using NaOMe in MeOH quantitatively afforded 1a. The reaction using AllMgCl and n-BuLi similarly gave the mixtures of 6-O-acetyl-1-C-allyl-2,3,4-tri-O-benzyl-α-d-glucopyranose (11b) and 1-C-allyl-2,3,4-tri-O-benzyl-α-d-glucopyranose (1b) in 30% and 54% yields, and of 6-O-acetyl-2,3,4-tri-O-benzyl-1-C-n-butyl-d-glucopyranose (11c) and 2,3,4-tri-O-benzyl-1-C-n-butyl-α-d-glucopyranose (1c) in 64% and 12% yields, respectively. The reactions using PhMgCl and PhCH₂MgCl afforded 6-O-acetyl-2,3,4-tri-O-benzyl-1-C-phenyl-α-d-glucopyranose (11d) and 6-O-acetyl-1-C-benzyl-2,3,4-tri-O-benzyl-α-d-glucopyranose (11e) in 89% and 82% yields, respectively, with almost no production of the deacetylated compounds. It seemed that these bulky organometallic reagents were apt to produce the nucleophilic attack on the conformationally fixed carbonyl group at C-1 of 10 rather than on the acetyl group at C-6. The treatment of 11b-e using NaOMe in MeOH quantitatively afforded 1b-e. 2,3,4-Tri-O-benzyl-1-C-methyl-α-d-mannopyranose (6a) was similarly prepared in 82% yield from 6-O-acetyl-2,3,4-tri-O-benzyl-d-manno-1,5-lactone(13). Preparation of 9 and 12 was reported in the following literature. See:

9a Koto S. Morishima N. Takenaka K. Kanemitsu K. Shimoura N. Kase M. Kojiro S. Nakamura T. Kawase T. Zen S. Bull. Chem. Soc. Jpn.  1989,  62:  3549 

9b Murakata C. Ogawa T. Carbohydr. Res.  1992,  235:  95 

9c The oxidation of 9 using pyridinium chlorochromate also gave 10 in a moderate yield. See: Horito S. Asano K. Umemura K. Hashimoto H. Yoshimura J. Carbohydr. Res.  1983,  121:  175 

10a Boon G.-J. Isles S. Setala P. Synlett  1995,  755 

10b Bernlind C. Oscarson S. J. Org. Chem.  1998,  63:  7780 

11 Grindley TB. Glycoscience: Chemistry and Chemical Biology I   Fraser-Reid B. Tatsuta K. Thieme J. Springer; Berlin: 2001.  p.4-51  

12

Typical Intramolecular Glycosidation Procedure (Table 1, Entry 4).
A typical glycosidation procedure is as follows. To a stirred solution of TfOH (0.48 µL, 0.0054 mmol) was added 1a (50 mg, 0.11 mmol) in MeCN (2 mL) at 0 °C in the presence of dry MgSO₄ (ca. 100 mg) in an Ar atmosphere. The resulting mixture was stirred for 2 h. The reaction was then quenched by the addition of a sat. NaHCO₃ solution (5 mL). The reaction mixture was extracted with EtOAc, and the organic layer was washed with H₂O and a sat. NaCl solution. After the organic layer was dried over Na₂SO₄, the solvent was evaporated under reduced pressure. The crude product was purified by preparative silica gel TLC (EtOAc-hexane = 1:2) to give 2a (45 mg, 93%).
Compound 2a: [α]_D ²³ -47.7 (c 1.54, CHCl₃). ¹H NMR (600 MHz, CDCl₃): δ = 1.49 (3 H, s, H-2′), 3.23 (1 H, s, H-4), 3.31 (1 H, s, H-2), 3.59 (1 H, s, H-3), 3.75 (1 H, dd, J = 6.2 Hz, J = 6.9 Hz, H-7a), 3.96 (1 H, d, J = 6.9 Hz, H-7b), 4.34-4.39 (3 H, m, OCH ₂Ph and OCHaHbPh), 4.53 (1 H, m, OCHaHbPh), 4.53 (1 H, d, J = 6.2 Hz, H-1), 4.58-4.61 (2 H, m, OCH ₂ Ph). ¹³C NMR (150 MHz, CDCl₃): δ = 21.0 (C-2′), 65.5 (C-7), 71.0 (OCH₂Ph), 71.2 (OCH₂Ph), 72.3 (OCH₂Ph), 74.5 (C-2), 75.2 (C-3), 75.7 (C-1), 77.3 (C-4), 107.0 (C-5). HRMS (ESI): m/z calcd for C₂₈H₃₀O₅Na⁺: 469.1991; found: 469.2032.
Compound 2b: [α]_D ²³ +7.6 (c 4.57, CHCl₃). ¹H NMR (600 MHz, CDCl₃): δ = 2.56 (1 H, dd, J = 7.6 Hz, J = 14.4 Hz, H-2′a), 2.64 (1 H,dd, J = 7.6 Hz, J = 14.4 Hz, H-2′b), 3.24 (1 H, s, H-4), 3.26 (1 H, s, H-2), 3.54 (1 H, s, H-3), 3.66 (1 H, dd, J = 6.2 Hz, J = 6.9 Hz, H-7a), 3.94 (1 H, d, J = 6.9 Hz, H-7b), 4.29-4.34 (3 H, m, OCH ₂Ph and OCHaHbPh), 4.41-4.52 (3 H, m, OCH ₂Ph and OCHaHbPh), 4.56 (1 H, d, J = 5.5 Hz, H-1), 5.03-5.05 (2 H, m, H-4′), 5.77 (1 H, m, H-3′). ¹³C NMR (150 MHz, CDCl₃): δ = 38.1 (C-2′), 65.7 (C-7), 70.9 (OCH₂Ph), 71.5 (OCH₂Ph), 72.2 (OCH₂Ph), 74.6 (C-2), 74.9 (C-3), 75.5 (C-1), 76.2 (C-4), 107.2 (C-5), 118.4 (C-4′), 132.0 (C-3′). HRMS (ESI): m/z calcd for C₃₀H₃₂O₅Na⁺: 495.2147; found: 495.2195.
Compound 2c: [α]_D ²³ -36.7 (c 1.08, CHCl₃). ¹H NMR (600 MHz, CDCl₃): δ = 0.84 (3 H, t, J = 6.9 Hz, H-5′), 1.16 (1 H, m, H-3′a), 1.25 (2 H, m, H-4′), 1.36 (1 H, m, H-3′b), 1.75 (1 H, m, H-2′a), 1.90 (1 H, ddd, J = 13.1 Hz, J = 3.4 Hz, J = 13.7 Hz, H-2′b), 3.25 (1 H, s, H-4), 3.31 (1 H, s, H-2), 3.60 (1 H, s, H-3), 3.70 (1 H, dd, J = 6.9 Hz, J = 6.2 Hz, H-7a), 3.98 (1 H, d, J = 6.9 Hz, H-7b), 4.32-4.40 (3 H, m, OCH ₂Ph and OCHaHbPh), 4.49-4.57 (3 H, m, OCH ₂Ph and OCHaHbPh), 4.59 (1 H, d, J = 6.2 Hz, H-1). ¹³C NMR (150 MHz, CDCl₃): δ = 14.0 (C-5′), 22.9 (C-4′), 24.1 (C-3′), 32.9 (C-2′), 65.6 (C-7), 70.9 (OCH₂Ph), 71.4 (OCH₂Ph), 72.0 (OCH₂Ph), 74.7 (C-2), 75.0 (C-3), 75.4 (C-1), 76.2 (C-4), 107.9 (C-5). HRMS (ESI): m/z calcd for C₃₁H₃₆O₅Na⁺: 511.2460; found: 511.2510.
Compound 2d: [α]_D ²³ -3.5 (c 2.71, CHCl₃). ¹H NMR (600 MHz, CDCl₃): δ = 3.39 (1 H, s, H-4), 3.50 (1 H, s, H-2), 3.68 (1 H, s, H-3), 3.81 (1 H, dd, J = 5.5 Hz, J = 6.2 Hz, H-7a), 4.03 (2 H, dd, J = 12.4 Hz, J = 3.4 Hz, OCH ₂Ph), 4.07 (1 H, d, J = 6.9 Hz, H-7b), 4.34 (2 H, dd, J = 12.4 Hz, J = 3.4 Hz, OCH ₂Ph), 4.56 (1 H, d, J = 13.1 Hz, OCHaHbPh), 4.67 (1 H, d, J = 13.1 Hz, OCHaHbPh), 4.79 (1 H, d, J = 6.2 Hz, H-1). ¹³C NMR (150 MHz, CDCl₃): δ = 65.6 (C-7), 71.0 (OCH₂Ph), 71.6 (OCH₂Ph), 72.2 (OCH₂Ph), 74.6 (C-2), 76.2 (C-3), 76.3 (C-1), 77.6 (C-4), 106.9 (C-5). HRMS (ESI): m/z calcd for C₃₃H₃₂O₅Na⁺: 531.2147; found: 531.2196.
Compound 5d: [α]_D ²³ -74.5 (c 0.47, CHCl₃). ¹H NMR (600 MHz, CDCl₃): δ = 3.55 (1 H, s, H-2), 3.77 (1 H, d, J = 5.5 Hz, H-4), 3.86 (1 H, d, J = 5.5 Hz, H-3), 3.94 (1 H, dd, J = 8.2 Hz, J = 5.5 Hz, H-7a), 3.95 (1 H, d, J = 11.7 Hz, OCHaHbPh), 4.04 (1 H, d, J = 11.7 Hz, OCHaHbPh), 4.42 (1 H, d, J = 8.2 Hz, H-7b), 4.44 (1 H, d, J = 12.4 Hz, OCHa′Hb′Ph), 4.45 (1 H, d, J = 12.4 Hz, OCHa′Hb′Ph), 4.53 (1 H, d, J = 12.4 Hz, OCHa′′Hb′′Ph), 4.63 (1 H, d, J = 6.2 Hz, H-1), 4.66 (1 H, d, J = 12.4 Hz, OCHa′′Hb′′Ph). ¹³C NMR (150 MHz, CDCl₃): δ = 66.1 (C-7), 71.2 (OCH₂Ph), 72.4 (OCH₂Ph), 73.3 (OCH₂Ph), 75.0 (C-3), 75.4 (C-1), 76.9 (C-2), 77.7 (C-4), 107.6 (C-5). HRMS (ESI): m/z calcd for C₃₃H₃₂O₅Na⁺: 531.2147; found: 531.2178.
Compound 2e: [α]_D ²³ -35.1 (c 2.32, CHCl₃). ¹H NMR (600 MHz, CDCl₃): δ = 2.97 (1 H, d, J = 13.4 Hz, H-2′a), 3.23 (1 H, s, H-4), 3.29 (1 H, s, H-2), 3.34 (1 H, d, J = 13.7 Hz, H-2′b), 3.45 (1 H, dd, J = 6.9 Hz, J = 6.2 Hz, H-7a), 3.60 (1 H, s, H-3), 3.91 (1 H, d, J = 6.9 Hz, H-7b), 4.33 (3 H, m, OCH ₂Ph and OCHaHbPh), 4.43 (1 H, d, J = 12.4 Hz, OCHa′Hb′Ph), 4.50 (1 H, d, J = 12.4 Hz, OCHaHbPh), 4.53 (1 H, d, J = 5.5 Hz, H-1), 4.56 (1 H, d, J = 13.0 Hz, OCHa′Hb′Ph). ¹³C NMR (150 MHz, CDCl₃): δ = 39.5 (C-2′), 65.7 (C-7), 70.9 (OCH₂Ph), 71.5 (OCH₂Ph), 72.0 (OCH₂Ph), 74.5 (C-2), 74.9 (C-3), 75.3 (C-1), 76.8 (C-4), 107.2 (C-5). HRMS (ESI): m/z calcd for C₃₄H₃₄O₅Na⁺: 545.2304; found: 545.2354.
Compound 5e: [α]_D ²³ -19.3 (c 1.97, CHCl₃). ¹H NMR (600 MHz, CDCl₃): δ = 2.95 (1 H, d, J = 14.4 Hz, H-2′a), 3.43 (1 H, d, J = 14.4 Hz, H-2′b), 3.48 (1 H, d, J = 1.4 Hz, H-2), 3.52 (1 H, dd, J = 6.9 Hz, J = 5.5 Hz, H-7a), 3.56 (1 H, d, J = 4.8 Hz, H-4), 3.81 (1 H, dd, J = 5.5 Hz, J = 1.4 Hz, H-3), 4.12 (1 H, d, J = 6.9 Hz, H-7b), 4.26 (1 H, d, J = 11.7 Hz, OCHaHbPh), 4.40 (1 H, d, J = 5.5 Hz, H-1), 4.43-4.51 (5 H, m, OCH ₂Ph × 2 and OCHaHbPh). ¹³C NMR (150 MHz, CDCl₃): δ = 39.1 (C-2′) 65.9 (C-7), 71.2 (OCH₂Ph), 71.3 (OCH₂Ph), 73.0 (OCH₂Ph), 74.2 (C-3), 75.1 (C-1), 76.2 (C-2), 76.5 (C-4), 107.8 (C-5). HRMS (ESI): m/z calcd for C₃₄H₃₄O₅Na⁺: 545.2304; found: 545.2352.
Compound 7a: [α]_D ²³ +12.1 (c 2.4, CHCl₃). ¹H NMR (600 MHz, CDCl₃): δ = 1.52 (3 H, s, H-2′), 3.48 (1 H, s, H-2), 3.53 (1 H, d, J = 5.5 Hz, H-4), 3.78-3.81 (2 H, m, H-3 and H-7a), 4.18 (1 H, d, J = 7.6 Hz, H-7b), 4.38 (1 H, d, J = 12.4 Hz, OCHaHbPh), 4.44-4.50 (4 H, m, H-1 and OCH ₂Ph and OCHaHbPh), 4.53-4.56 (2 H, m, OCH ₂Ph). ¹³C NMR (150 MHz, CDCl₃): δ = 20.9 (C-2′), 65.7 (C-7), 71.2 (OCH₂Ph), 71.7 (OCH₂Ph), 73.1 (OCH₂Ph), 74.1 (C-3), 75.1 (C-1), 76.3 (C-2), 77.1 (C-4), 107.1 (C-5). HRMS (ESI): m/z calcd for C₂₈H₃₀O₅Na⁺: 469.1991; found: 469.2030.

Scheme 3